Recent Articles
A Practitioner Statement on the Responsible Development of Ibogaine in the United States – Open Letter
Dear Colleagues,We write as a collective of practitioners, researchers, clinicians, and integration specialists with direct, long-term experience working with iboga and ibogaine across a range of settings. The growing interest in ibogaine within the United States — including public investment, emerging clinical pathways, and public-private partnerships — represents a meaningful shift in how this modality […]
Filter
Senate Bill S.4031 Signals a Federal Turn Toward Psychedelic Medicine
Senate bill S.4031 would establish VA Centers of Excellence to study psychedelic therapies — including…
By Joe Moore
Colorado’s Ibogaine Bill Could Be a Landmark — If It Respects the Plant’s Roots
HB26-1325 would create a state-supported ibogaine research program to study addiction and PTSD treatment, including…
By Joe Moore
Navigating Colorado’s Regulated Psychedelic Model: Lessons From the Front Lines
Entering the legal, regulated model of psychedelic therapy was the last thing on my mind…
By Jillian Gordon
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
What if classic psychedelic medicines like psilocybin don’t heal primarily by changing brain chemistry, but…
By Scott Shannon, MD – Wholeness Center, Fort Collins, Colorado
Couples Are Turning to Ketamine-Assisted Therapy to Heal Their Relationships
As couples’ therapists, we see the same painful sticking points again and again. Couples arrive…
By Chandra E. Khalifian, PhD, Skylar Kelsven, PhD, Kayla C. Knopp, PhD
Patient Safety After a Death: What Transparency Can and Cannot Do
A Tragedy at an Ibogaine Clinic — and the Policy Failure Behind It A patient…